Página Nct de ensaios clínicos
Clinical Trial Results:
A randomised, parallel-group, double-blind, placebo-controlled Phase III trial assessing the efficacy and safety of ALK Grass Tablet Phleum pratense in subjects with seasonal grass pollen induced rhinoconjunctivitis
| Summary | |
EudraCT number | 2004-000083-27 |
Trial protocol | SE IT ES AT GB |
Global completion date | 26 Mar 2010 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 13 Mar 2016 |
First version publication date | 13 Mar 2016 |
Other versions | |
Summary report(s) | GT-08 Synopsis GT-08 Extension Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.